Quantum Playmakers D‑Wave and Rigetti React to $2 B Federal Boost – Which Holds More Upside?

The U.S. government's recent allocation of roughly $2 billion for quantum research has singled out two companies that already trade on public exchanges: D‑Wave Systems (QBTS) and Rigetti Computing (RGTI). Both firms were announced as potential recipients of up to $100 million in funding, a signal that the administration sees commercial promise in their technologies. The news sent QBTS up about 15% and RGTI higher still, gaining roughly 23% in a single session while the broader market barely moved.

D‑Wave distinguishes itself by concentrating on quantum annealing hardware that can be offered as a cloud service today. Its recent $10 million, two‑year contract with a Fortune‑100 customer underscores an emerging revenue stream tied to optimization problems in logistics, manufacturing and supply‑chain planning. Because these use cases already generate paying business, D‑Wave enjoys a clearer path to cash flow than many peers still locked in pure research.

Rigetti, by contrast, is pursuing the gate‑model approach that promises universal quantum computation but remains farther from commercial scale. The company’s first‑quarter revenue nearly tripled year over year to $4.4 million, and its 108‑qubit Cepheus processor is now accessible through major cloud platforms. However, Rigetti’s roadmap hinges on improving qubit fidelity and error correction – technical milestones that may take several more years before they translate into sizable sales.

From an investment perspective, the two stocks present distinct risk‑return profiles. D‑Wave trades at a forward price‑to‑sales multiple of roughly 248× for the next twelve months, well above the historical average for technology firms but slightly below its own one‑year median. Analysts’ consensus price target suggests a potential upside of about 32% from the current $30.14 level, reflecting optimism that federal backing will accelerate customer adoption and lift near‑term earnings.

Rigetti’s valuation is similarly lofty, with a forward sales multiple in the high‑200s. The analyst community projects a roughly 26% price increase relative to today’s market price. While the CHIPS Act funding could ease the burden of research spending, the company remains heavily dependent on breakthroughs in fault‑tolerant hardware – an outcome that is still uncertain and may not materialize within the next earnings cycle.

Technical indicators add nuance to the fundamental picture. QBTS sits comfortably above both its 50‑day and 200‑day moving averages, with a relative strength index near 65, indicating bullish momentum but also approaching overbought territory. Its one‑month return of nearly 65% vastly outpaced the S&P 500’s 6%, delivering an excess return that has attracted short‑term traders. RGTI, meanwhile, posted a spectacular weekly gain of over 17% and is likewise trading above key trend lines, though its volatility remains elevated.

For investors weighing exposure to the quantum sector, D‑Wave may be the more defensible play in the near term because of its revenue‑generating contracts and clearer commercial use cases. Rigetti offers a higher‑risk, potentially higher‑reward proposition for those willing to bet on a future where gate‑model machines become mainstream. Both stocks carry significant valuation premiums, so any upside will likely require sustained execution beyond the initial government funding.

In summary, the federal endorsement has injected fresh capital and market enthusiasm into an emerging industry that remains in its infancy. While the $100 million grants are modest relative to the overall $2 billion pot, they provide a tangible catalyst for both firms. D‑Wave’s focus on optimization services positions it as the current cash‑flow leader, whereas Rigetti’s ambition to build scalable quantum processors could pay off dramatically if technical hurdles are overcome. Investors should balance these dynamics against the high price multiples and consider how each company fits within their broader portfolio risk tolerance.